Who founded Talaris Therapeutics?

Talaris Therapeutics was founded by Suzanne Ildstad.

Who are Talaris Therapeutics's investors?

Talaris Therapeutics's investors include Keyhorse Capital, Qiming Venture Partners USA, Blackstone Life Sciences, Citadel, Invus, Longitude Capital, Qiming Healthcare, Viking Global Investors.

How much funding has Talaris Therapeutics raised?

Talaris Therapeutics has disclosed $115M raised across 1 of its 2 known rounds.

Where is Talaris Therapeutics headquartered?

Talaris Therapeutics is headquartered in Louisville, US.

Talaris Therapeutics

Louisville, US · Delaware corporation · 8 known investors

Find your way into Talaris Therapeutics

Your email: who you already know at Talaris Therapeutics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Talaris Therapeutics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Biotech

Founders & leadership

Suzanne IldstadFounder

Scott RequadtExecutive

Geoff MackayNamed on SEC filing

Francois NaderNamed on SEC filing

Board

Sandip Agarwala Board Member2018–2023Managing Director at Blue Owl Capital

Mark McDade Board directorGeneral Partner at Qiming Healthcare

Nick GalakatosBoard director

Investors · 8

Keyhorse Capitallisted by Keyhorse CapitalLexington

How we know: Keyhorse Capital's portfolio page · Not right? Tell us

Qiming Venture Partners USAlisted by Qiming Venture Partners USACambridge

How we know: Qiming Venture Partners USA's portfolio page · biospace.com · Not right? Tell us

Blackstone Life SciencesreportedNew York · $20M – $60M

How we know: biospace.com · Not right? Tell us

Citadelreported

How we know: funding news · Not right? Tell us

InvusreportedNew York

How we know: funding news · Not right? Tell us

Longitude CapitalreportedMenlo Park · $10M – $30M

How we know: biospace.com · Not right? Tell us

Qiming HealthcareinferredBellevue

How we know: board seat on SEC Form D · Not right? Tell us

Viking Global InvestorsreportedStamford

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$115M disclosed across 1 of 2 rounds · 2019–2020

Undisclosed amountSeries AApr 2019
Blackstone Life Sciences (lead), Longitude Capital, Qiming Venture Partners USA
Source ↗

▶$115MraisedOct 2020 · 24 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sandip AgarwalaDirector
Scott RequadtExecutive Officer, Director
Geoff MackayDirector
Francois NaderDirector
Mark McDadeDirector
Nick GalakatosDirector
Suzanne IldstadExecutive Officer, Director

Offering amount: $115M
Amount sold: $115M
First sale: Sep 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Talaris Therapeutics?: Talaris Therapeutics was founded by Suzanne Ildstad.
Who are Talaris Therapeutics's investors?: Talaris Therapeutics's investors include Keyhorse Capital, Qiming Venture Partners USA, Blackstone Life Sciences, Citadel, Invus, Longitude Capital, Qiming Healthcare, Viking Global Investors.
How much funding has Talaris Therapeutics raised?: Talaris Therapeutics has disclosed $115M raised across 1 of its 2 known rounds.
Where is Talaris Therapeutics headquartered?: Talaris Therapeutics is headquartered in Louisville, US.